Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
J. Clin. Oncol 2023 Jul 19;[EPub Ahead of Print], M Ingham, JB Allred, L Chen, B Das, B Kochupurakkal, K Gano, S George, S Attia, MA Burgess, M Seetharam, SA Boikos, N Bui, JL Chen, JL Close, GM Cote, PH Thaker, SP Ivy, S Bose, A D'Andrea, A Marino-Enriquez, GI Shapiro, GK SchwartzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.